EURI B Stock Overview
European Institute of Science AB manufactures and sells diagnostic assays for the clinical laboratory and point-of-care settings, and point-of-care instrumentation for diagnostic applications in Sweden.
European Institute of Science AB Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||kr0.12|
|52 Week High||kr0.37|
|52 Week Low||kr0.02|
|1 Month Change||241.67%|
|3 Month Change||68.49%|
|1 Year Change||6.03%|
|3 Year Change||-30.51%|
|5 Year Change||-63.93%|
|Change since IPO||-95.44%|
Recent News & Updates
|EURI B||SE Biotechs||SE Market|
Return vs Industry: EURI B exceeded the Swedish Biotechs industry which returned -27.5% over the past year.
Return vs Market: EURI B exceeded the Swedish Market which returned -24% over the past year.
|EURI B volatility|
|EURI B Average Weekly Movement||80.3%|
|Biotechs Industry Average Movement||7.8%|
|Market Average Movement||7.4%|
|10% most volatile stocks in SE Market||12.2%|
|10% least volatile stocks in SE Market||4.6%|
Stable Share Price: EURI B is more volatile than 90% of Swedish stocks over the past 3 months, typically moving +/- 80% a week.
Volatility Over Time: EURI B's weekly volatility has increased from 43% to 80% over the past year.
About the Company
European Institute of Science AB manufactures and sells diagnostic assays for the clinical laboratory and point-of-care settings, and point-of-care instrumentation for diagnostic applications in Sweden. It primarily focuses on the diagnostic assays and instrumentation for canine, feline, and equine animals. The company’s products include TurboReader point-of-care instruments that performs measurements using disposable cuvettes; Canine C-Reactive (CRP) TurboReader assays for the quantitative determination of Canine CRP in dog serum or plasma; Feline Hp (Haptoglobin) TurboReader assay for determining Hp in cat serum or plasma; Feline SAA TurboReader assay for the determination of serum amyloid A (SAA) in cat serum or plasma; and Equine SAA TurboReader assay for determining SAA in horse serum or plasma.
European Institute of Science AB Fundamentals Summary
|EURI B fundamental statistics|
Is EURI B overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|EURI B income statement (TTM)|
|Cost of Revenue||kr180.00k|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.031|
|Net Profit Margin||-519.65%|
How did EURI B perform over the long term?See historical performance and comparison